{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:11:33Z","timestamp":1792653093935,"version":"4.5.0"},"reference-count":244,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.semcancer.2020.12.024","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T21:20:17Z","timestamp":1611004817000},"page":"83-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Exploring the clinical value of tumor microenvironment in platinum-resistant ovarian cancer"],"prefix":"10.1016","volume":"77","author":[{"given":"Alia","family":"Ghoneum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameh","family":"Almousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5460-5417","authenticated-orcid":false,"given":"Bailey","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar Yasser","family":"Abdulfattah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjun","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hebatullah","family":"Abouelfadl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Livingston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7904-2558","authenticated-orcid":false,"given":"Neveen","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0005","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: a review","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biol. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5732\/cjc.014.10274","article-title":"Ovarian cancer standard of care: are there real alternatives?","volume":"34","author":"Della Pepa","year":"2015","journal-title":"Chin. J. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3802\/jgo.2013.24.1.83","article-title":"Advanced ovarian cancer: what should be the standard of care?","volume":"24","author":"Goff","year":"2013","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.semcancer.2020.12.024_bib0025","article-title":"Genomic profiling of platinum-resistant ovarian cancer: the road into druggable targets","author":"da Costa","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2020.12.024_bib0030","doi-asserted-by":"crossref","DOI":"10.1177\/1179299X19860815","article-title":"Chemotherapy resistance in advanced ovarian Cancer patients","volume":"11","author":"Pokhriyal","year":"2019","journal-title":"Biomark. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2020.12.024_bib0035","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ygyno.2014.02.038","article-title":"\u201cPlatinum resistant\u201d ovarian cancer: what is it, who to treat and how to measure benefit?","volume":"133","author":"Davis","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.semcancer.2020.12.024_bib0040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ygyno.2016.05.020","article-title":"Primary and acquired platinum-resistance among women with high grade serous ovarian cancer","volume":"142","author":"Slaughter","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.semcancer.2020.12.024_bib0045","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1172\/JCI74778","article-title":"Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion","volume":"124","author":"Kenny","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.semcancer.2020.12.024_bib0050","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1172\/JCI33775","article-title":"The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin","volume":"118","author":"Kenny","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.semcancer.2020.12.024_bib0055","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.semcancer.2020.12.024_bib0060","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.bbagen.2018.11.005","article-title":"Mechanisms underlying acquired platinum resistance in high grade serous ovarian cancer - a mini review","volume":"1863","author":"Binju","year":"2019","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"10.1016\/j.semcancer.2020.12.024_bib0065","article-title":"New approaches for targeting platinum-resistant ovarian cancer","author":"McMullen","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"15","key":"10.1016\/j.semcancer.2020.12.024_bib0070","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2020.12.024_bib0075","article-title":"Lessons learned from understanding chemotherapy resistance in epithelial tubo-ovarian carcinoma from BRCA1and BRCA2mutation carriers","author":"Le Page","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"7","key":"10.1016\/j.semcancer.2020.12.024_bib0080","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc1123","article-title":"Ovarian cancer: strategies for overcoming resistance to chemotherapy","volume":"3","author":"Agarwal","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"31","key":"10.1016\/j.semcancer.2020.12.024_bib0085","doi-asserted-by":"crossref","first-page":"49710","DOI":"10.18632\/oncotarget.10436","article-title":"Increasing sensitivity to DNA damage is a potential driver for human ovarian cancer","volume":"7","author":"Jin","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2020.12.024_bib0090","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.phrs.2016.01.001","article-title":"Cisplatin resistance and opportunities for precision medicine","volume":"106","author":"Amable","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.semcancer.2020.12.024_bib0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12916-015-0278-7","article-title":"New horizons in tumor microenvironment biology: challenges and opportunities","volume":"13","author":"Chen","year":"2015","journal-title":"BMC Med."},{"issue":"31","key":"10.1016\/j.semcancer.2020.12.024_bib0100","doi-asserted-by":"crossref","first-page":"49310","DOI":"10.18632\/oncotarget.10336","article-title":"Desferal regulates hCtr1 and transferrin receptor expression through Sp1 and exhibits synergistic cytotoxicity with platinum drugs in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.semcancer.2020.12.024_bib0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19051486","article-title":"Modulating chemosensitivity of tumors to platinum-based antitumor drugs by transcriptional regulation of copper homeostasis","volume":"19","author":"Lai","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"27","key":"10.1016\/j.semcancer.2020.12.024_bib0110","doi-asserted-by":"crossref","first-page":"13905","DOI":"10.1074\/jbc.M116.731281","article-title":"Cathepsin protease controls copper and cisplatin accumulation via cleavage of the Ctr1 metal-binding ectodomain","volume":"291","author":"Ohrvik","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.semcancer.2020.12.024_bib0115","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ygyno.2011.04.025","article-title":"Prognostic value of the copper transporters, CTR1 and CTR2, in patients with ovarian carcinoma receiving platinum-based chemotherapy","volume":"122","author":"Lee","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.semcancer.2020.12.024_bib0120","first-page":"1409","article-title":"Association of copper transporter expression with platinum resistance in epithelial ovarian cancer","volume":"33","author":"Yoshida","year":"2013","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.semcancer.2020.12.024_bib0125","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.3892\/ol.2015.3531","article-title":"Expression of the copper transporters hCtr1, ATP7A and ATP7B is associated with the response to chemotherapy and survival time in patients with resected non-small cell lung cancer","volume":"10","author":"Yang","year":"2015","journal-title":"Oncol. Lett."},{"issue":"16 Pt 1","key":"10.1016\/j.semcancer.2020.12.024_bib0130","first-page":"5853","article-title":"Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients","volume":"9","author":"Samimi","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.semcancer.2020.12.024_bib0135","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1368-8375(02)00038-6","article-title":"Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human oral squamous cell carcinoma treated with cisplatin","volume":"39","author":"Miyashita","year":"2003","journal-title":"Oral Oncol."},{"issue":"3","key":"10.1016\/j.semcancer.2020.12.024_bib0140","first-page":"337","article-title":"Expression of copper-transporting P-type adenosine triphosphatase in human esophageal carcinoma","volume":"11","author":"Higashimoto","year":"2003","journal-title":"Int. J. Mol. Med."},{"issue":"8","key":"10.1016\/j.semcancer.2020.12.024_bib0145","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1158\/1078-0432.CCR-03-0454","article-title":"Prognostic value of the Cu-transporting ATPase in ovarian carcinoma patients receiving cisplatin-based chemotherapy","volume":"10","author":"Nakayama","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.semcancer.2020.12.024_bib0150","doi-asserted-by":"crossref","DOI":"10.3390\/cells8091080","article-title":"Activity and trafficking of copper-transporting ATPases in tumor development and defense against platinum-based drugs","volume":"8","author":"Petruzzelli","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1124\/mol.66.1.25","article-title":"Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B","volume":"66","author":"Samimi","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"11","key":"10.1016\/j.semcancer.2020.12.024_bib0160","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1158\/1078-0432.CCR-08-2306","article-title":"Therapeutic targeting of ATP7B in ovarian carcinoma","volume":"15","author":"Mangala","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2020.12.024_bib0165","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fphar.2020.00343","article-title":"The drug-resistance mechanisms of five platinum-based antitumor agents","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.semcancer.2020.12.024_bib0170","doi-asserted-by":"crossref","DOI":"10.4061\/2010\/201367","article-title":"Cellular responses to Cisplatin-induced DNA damage","volume":"2010","author":"Basu","year":"2010","journal-title":"J. Nucleic Acids"},{"key":"10.1016\/j.semcancer.2020.12.024_bib0175","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.semcancer.2020.12.024_bib0180","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2020.12.024_bib0185","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1755-8794-2-34","article-title":"Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer","volume":"2","author":"Li","year":"2009","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/j.semcancer.2020.12.024_bib0190","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fonc.2017.00024","article-title":"The unique molecular and cellular microenvironment of ovarian Cancer","volume":"7","author":"Worzfeld","year":"2017","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.semcancer.2020.12.024_bib0195","doi-asserted-by":"crossref","first-page":"C444","DOI":"10.1152\/ajpcell.00188.2015","article-title":"Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: cell and Molecular Processes in Cancer metastasis","volume":"309","author":"Yeung","year":"2015","journal-title":"Am. J. Physiol., Cell Physiol."},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0200","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10555-013-9456-2","article-title":"Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition","volume":"33","author":"Thibault","year":"2014","journal-title":"Cancer Metastasis Rev."},{"issue":"7353","key":"10.1016\/j.semcancer.2020.12.024_bib0205","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Cancer Genome Atlas Research, N","year":"2011","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.semcancer.2020.12.024_bib0210","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.cell.2016.05.069","article-title":"Integrated proteogenomic characterization of human high-grade serous ovarian Cancer","volume":"166","author":"Zhang","year":"2016","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.semcancer.2020.12.024_bib0215","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1002\/ijc.21599","article-title":"Molecular profiling of platinum resistant ovarian cancer","volume":"118","author":"Helleman","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"7578","key":"10.1016\/j.semcancer.2020.12.024_bib0220","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nature15716","article-title":"Corrigendum: whole-genome characterization of chemoresistant ovarian cancer","volume":"527","author":"Patch","year":"2015","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.semcancer.2020.12.024_bib0225","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.3390\/ijms20102505","article-title":"ERK is a pivotal player of Chemo-Immune-Resistance in Cancer","volume":"20","author":"Salaroglio","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.semcancer.2020.12.024_bib0230","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tcb.2014.12.006","article-title":"Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance","volume":"25","author":"Seguin","year":"2015","journal-title":"Trends Cell Biol."},{"issue":"2","key":"10.1016\/j.semcancer.2020.12.024_bib0235","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3390\/cancers12020287","article-title":"Chemokines and their receptors: multifaceted roles in Cancer progression and potential value as Cancer prognostic markers","volume":"12","author":"Do","year":"2020","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.semcancer.2020.12.024_bib0240","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1124\/mol.62.3.660","article-title":"Akt activation induced by lysophosphatidic acid and sphingosine-1-phosphate requires both mitogen-activated protein kinase kinase and p38 mitogen-activated protein kinase and is cell-line specific","volume":"62","author":"Baudhuin","year":"2002","journal-title":"Mol. Pharmacol."},{"issue":"10","key":"10.1016\/j.semcancer.2020.12.024_bib0245","first-page":"5263","article-title":"Lysophosphatidic acid stimulates urokinase receptor (uPAR\/CD87) in ovarian epithelial Cancer cells","volume":"35","author":"Lizalek","year":"2015","journal-title":"Anticancer Res."},{"issue":"2","key":"10.1016\/j.semcancer.2020.12.024_bib0250","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1159\/000458744","article-title":"Lysophosphatidic acid promotes epithelial to mesenchymal transition in ovarian Cancer cells by repressing SIRT1","volume":"41","author":"Ray","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"6","key":"10.1016\/j.semcancer.2020.12.024_bib0255","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1158\/0008-5472.CAN-05-1292","article-title":"Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells","volume":"66","author":"Ren","year":"2006","journal-title":"Cancer Res."},{"issue":"20","key":"10.1016\/j.semcancer.2020.12.024_bib0260","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1182\/blood-2011-07-365825","article-title":"Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells","volume":"118","author":"Obermajer","year":"2011","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.semcancer.2020.12.024_bib0265","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1158\/0008-5472.CAN-11-2449","article-title":"PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment","volume":"71","author":"Obermajer","year":"2011","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.semcancer.2020.12.024_bib0270","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1158\/1541-7786.MCR-07-0001","article-title":"Normalization of the ovarian cancer microenvironment by SPARC","volume":"5","author":"Said","year":"2007","journal-title":"Mol. Cancer Res."},{"issue":"10","key":"10.1016\/j.semcancer.2020.12.024_bib0275","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1593\/neo.08672","article-title":"SPARC ameliorates ovarian cancer-associated inflammation","volume":"10","author":"Said","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/j.semcancer.2020.12.024_bib0280","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fendo.2017.00066","article-title":"The role of endocrine g protein-coupled receptors in ovarian Cancer progression","volume":"8","author":"Zhang","year":"2017","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"8","key":"10.1016\/j.semcancer.2020.12.024_bib0285","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1158\/1078-0432.CCR-10-2325","article-title":"Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells","volume":"17","author":"Rosano","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.semcancer.2020.12.024_bib0290","doi-asserted-by":"crossref","first-page":"e995025","DOI":"10.4161\/23723556.2014.995025","article-title":"Disrupting the endothelin and Wnt relationship to overcome chemoresistance","volume":"2","author":"Rosano","year":"2015","journal-title":"Mol. Cell. Oncol."},{"issue":"4","key":"10.1016\/j.semcancer.2020.12.024_bib0295","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2174\/156800911795538057","article-title":"Role of the renin-angiotensin system in gynecologic cancers","volume":"11","author":"Ino","year":"2011","journal-title":"Curr. Cancer Drug Targets"},{"issue":"11","key":"10.1016\/j.semcancer.2020.12.024_bib0300","doi-asserted-by":"crossref","first-page":"19700","DOI":"10.3390\/ijms151119700","article-title":"Cell-surface receptors transactivation mediated by g protein-coupled receptors","volume":"15","author":"Cattaneo","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0305","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.biocel.2009.10.016","article-title":"Integrated genomics of chemotherapy resistant ovarian cancer: a role for extracellular matrix, TGFbeta and regulating microRNAs","volume":"42","author":"Helleman","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"17","key":"10.1016\/j.semcancer.2020.12.024_bib0310","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.1158\/1078-0432.CCR-04-2682","article-title":"Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers","volume":"11","author":"Jazaeri","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2020.12.024_bib0315","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fonc.2013.00120","article-title":"Targeting nuclear factor-kappa B to overcome resistance to chemotherapy","volume":"3","author":"Godwin","year":"2013","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.semcancer.2020.12.024_bib0320","doi-asserted-by":"crossref","first-page":"e11198","DOI":"10.1371\/journal.pone.0011198","article-title":"Oncoproteomic analysis reveals co-upregulation of RELA and STAT5 in carboplatin resistant ovarian carcinoma","volume":"5","author":"Jinawath","year":"2010","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.semcancer.2020.12.024_bib0325","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1158\/0008-5472.CAN-13-0023","article-title":"TGF-beta modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment","volume":"73","author":"Yeung","year":"2013","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0330","doi-asserted-by":"crossref","first-page":"12522","DOI":"10.1038\/s41598-018-30978-6","article-title":"Novel oncogenic and chemoresistance-inducing functions of resistin in ovarian cancer cells require miRNAs-mediated induction of epithelial-to-mesenchymal transition","volume":"8","author":"Qiu","year":"2018","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.semcancer.2020.12.024_bib0335","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/ERC-11-0329","article-title":"Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients","volume":"19","author":"Gyorffy","year":"2012","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.semcancer.2020.12.024_bib0340","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1186\/1471-2407-14-837","article-title":"MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer","volume":"14","author":"P\u00e9nzv\u00e1lt\u00f3","year":"2014","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2020.12.024_bib0345","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1158\/2159-8274.CD-11-0010","article-title":"Ovarian cancer spheroids use myosin-generated force to clear the mesothelium","volume":"1","author":"Iwanicki","year":"2011","journal-title":"Cancer Discov."},{"issue":"5","key":"10.1016\/j.semcancer.2020.12.024_bib0350","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.trecan.2018.03.004","article-title":"Cancer as a matter of fat: the crosstalk between adipose tissue and tumors","volume":"4","author":"Lengyel","year":"2018","journal-title":"Trends Cancer"},{"issue":"44","key":"10.1016\/j.semcancer.2020.12.024_bib0355","doi-asserted-by":"crossref","first-page":"76116","DOI":"10.18632\/oncotarget.18814","article-title":"Cancer-associated fibroblasts enhance metastatic potential of lung cancer cells through IL-6\/STAT3 signaling pathway","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.semcancer.2020.12.024_bib0360","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/CAD.0000000000000858","article-title":"Targeted therapy clinical trials in ovarian cancer: improved outcomes by gene mutation screening","volume":"31","author":"Guo","year":"2020","journal-title":"Anticancer Drugs"},{"issue":"12","key":"10.1016\/j.semcancer.2020.12.024_bib0365","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/intimm\/dxv041","article-title":"Oxaliplatin regulates expression of stress ligands in ovarian cancer cells and modulates their susceptibility to natural killer cell-mediated cytotoxicity","volume":"27","author":"Siew","year":"2015","journal-title":"Int. Immunol."},{"key":"10.1016\/j.semcancer.2020.12.024_bib0370","doi-asserted-by":"crossref","first-page":"2368249","DOI":"10.1155\/2019\/2368249","article-title":"Tumour-associated macrophages (TAMs) in Colon Cancer and how to reeducate them","volume":"2019","author":"Yahaya","year":"2019","journal-title":"J. Immunol. Res."},{"issue":"8","key":"10.1016\/j.semcancer.2020.12.024_bib0375","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10080266","article-title":"Targeting the microenvironment in high grade serous ovarian Cancer","volume":"10","author":"Nwani","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0380","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1479-5876-2-23","article-title":"Peritoneal inflammation - a microenvironment for Epithelial Ovarian Cancer (EOC)","volume":"2","author":"Freedman","year":"2004","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.semcancer.2020.12.024_bib0385","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.2353\/ajpath.2007.060903","article-title":"Secreted protein acidic and rich in cysteine (SPARC) inhibits integrin-mediated adhesion and growth factor-dependent survival signaling in ovarian cancer","volume":"170","author":"Said","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0390","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/1097-0142(19940701)74:1<93::AID-CNCR2820740117>3.0.CO;2-P","article-title":"Transforming growth factor-beta inhibits proliferation of human ovarian cancer cells obtained from ascites","volume":"74","author":"Hurteau","year":"1994","journal-title":"Cancer"},{"issue":"15","key":"10.1016\/j.semcancer.2020.12.024_bib0395","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1158\/0008-5472.CAN-15-1227","article-title":"Interleukin-6 stimulates defective angiogenesis","volume":"75","author":"Gopinathan","year":"2015","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0400","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12943-019-0994-2","article-title":"Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance","volume":"18","author":"Fiori","year":"2019","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.semcancer.2020.12.024_bib0405","first-page":"2081","article-title":"CAFs enhance paclitaxel resistance by inducing EMT through the IL6\/JAK2\/STAT3 pathway","volume":"39","author":"Wang","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcancer.2020.12.024_bib0410","series-title":"Loss of Tenascin-X Expression During Tumor Progression: a New Pan-cancer Marker","author":"Liot","year":"2020"},{"issue":"2","key":"10.1016\/j.semcancer.2020.12.024_bib0415","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1242\/dmm.004077","article-title":"Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer","volume":"4","author":"Cox","year":"2011","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.semcancer.2020.12.024_bib0420","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.eml.2018.02.003","article-title":"Complex mechanics of the heterogeneous extracellular matrix in cancer","volume":"21","author":"Malandrino","year":"2018","journal-title":"Extreme Mech. Lett."},{"issue":"5957","key":"10.1016\/j.semcancer.2020.12.024_bib0425","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1126\/science.1176009","article-title":"The extracellular matrix: not just pretty fibrils","volume":"326","author":"Hynes","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2020.12.024_bib0430","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fonc.2015.00245","article-title":"The extracellular matrix in epithelial ovarian Cancer - a piece of a puzzle","volume":"5","author":"Cho","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcancer.2020.12.024_bib0435","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3389\/fonc.2019.00688","article-title":"Targeting the interplay between Cancer fibroblasts, mesenchymal stem cells, and Cancer stem cells in desmoplastic cancers","volume":"9","author":"Chan","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcancer.2020.12.024_bib0440","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.47327","article-title":"FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy","volume":"8","author":"Diaz Osterman","year":"2019","journal-title":"Elife"},{"issue":"12","key":"10.1016\/j.semcancer.2020.12.024_bib0445","doi-asserted-by":"crossref","DOI":"10.3390\/biom9120788","article-title":"The impact of integrin-mediated matrix adhesion on cisplatin resistance of W1 ovarian Cancer cells","volume":"9","author":"Wantoch von Rekowski","year":"2019","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.semcancer.2020.12.024_bib0450","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/omi.2009.0008","article-title":"Quantitative proteomics analysis integrated with microarray data reveals that extracellular matrix proteins, catenins, and p53 binding protein 1 are important for chemotherapy response in ovarian cancers","volume":"13","author":"Pan","year":"2009","journal-title":"OMICS"},{"issue":"4","key":"10.1016\/j.semcancer.2020.12.024_bib0455","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1535-6108(03)00058-8","article-title":"Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells","volume":"3","author":"Sherman-Baust","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2020.12.024_bib0460","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/1471-2407-13-476","article-title":"Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer","volume":"13","author":"Ricciardelli","year":"2013","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2020.12.024_bib0465","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/sj.bjc.6605185","article-title":"Coexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression","volume":"101","author":"Chen","year":"2009","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.semcancer.2020.12.024_bib0470","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1593\/neo.12442","article-title":"Differential roles of uPAR in peritoneal ovarian carcinomatosis","volume":"14","author":"Al-Hassan","year":"2012","journal-title":"Neoplasia"},{"issue":"5","key":"10.1016\/j.semcancer.2020.12.024_bib0475","first-page":"473","article-title":"Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells","volume":"39","author":"Mikula-Pietrasik","year":"2016","journal-title":"Cell. Oncol. Dordr. (Dordr)"},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0480","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.1038\/s41598-017-07005-1","article-title":"Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells","volume":"7","author":"Sonego","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.semcancer.2020.12.024_bib0485","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/ijc.32854","article-title":"Ovarian cancer-associated mesothelial cells induce acquired platinum-resistance in peritoneal metastasis via the FN1\/Akt signaling pathway","volume":"146","author":"Yoshihara","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0490","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/carcin\/bgr230","article-title":"Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness","volume":"33","author":"Cai","year":"2012","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0495","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2011.01.011","article-title":"Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion","volume":"303","author":"Zhang","year":"2011","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.semcancer.2020.12.024_bib0500","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10110406","article-title":"Cancer associated fibroblasts: naughty neighbors that drive ovarian Cancer progression","volume":"10","author":"Dasari","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"25","key":"10.1016\/j.semcancer.2020.12.024_bib0505","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1038\/onc.2016.509","article-title":"A loop of cancer-stroma-cancer interaction promotes peritoneal metastasis of ovarian cancer via TNFalpha-TGFalpha-EGFR","volume":"36","author":"Lau","year":"2017","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0510","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1042\/BST20160387","article-title":"Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis","volume":"45","author":"Erdogan","year":"2017","journal-title":"Biochem. Soc. Trans."},{"issue":"33","key":"10.1016\/j.semcancer.2020.12.024_bib0515","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1038\/onc.2009.180","article-title":"Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells","volume":"28","author":"Sullivan","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2020.12.024_bib0520","doi-asserted-by":"crossref","first-page":"6685","DOI":"10.2147\/CMAR.S179189","article-title":"IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis","volume":"10","author":"Browning","year":"2018","journal-title":"Cancer Manag. Res."},{"issue":"11","key":"10.1016\/j.semcancer.2020.12.024_bib0525","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.semcancer.2020.12.024_bib0530","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.it.2017.03.002","article-title":"Immunological functions of the omentum","volume":"38","author":"Meza-Perez","year":"2017","journal-title":"Trends Immunol."},{"issue":"10","key":"10.1016\/j.semcancer.2020.12.024_bib0535","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.bbalip.2013.02.010","article-title":"Adipose tissue and adipocytes support tumorigenesis and metastasis","volume":"1831","author":"Nieman","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.semcancer.2020.12.024_bib0540","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ajpath.2013.04.023","article-title":"Milky spots promote ovarian cancer metastatic colonization of peritoneal adipose in experimental models","volume":"183","author":"Clark","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"11","key":"10.1016\/j.semcancer.2020.12.024_bib0545","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/obr.12450","article-title":"Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progression","volume":"17","author":"Chkourko Gusky","year":"2016","journal-title":"Obes. Rev."},{"issue":"3","key":"10.1016\/j.semcancer.2020.12.024_bib0550","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3892\/br.2017.955","article-title":"The conceptual advances of carcinogenic sequence model in high-grade serous ovarian cancer","volume":"7","author":"Kobayashi","year":"2017","journal-title":"Biomed. Rep."},{"issue":"65","key":"10.1016\/j.semcancer.2020.12.024_bib0555","doi-asserted-by":"crossref","first-page":"109417","DOI":"10.18632\/oncotarget.22684","article-title":"Estrogen receptor signaling mediates leptin-induced growth of breast cancer cells via autophagy induction","volume":"8","author":"Raut","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0560","first-page":"5","article-title":"Gynaecological cancers and leptin: a focus on the endometrium and ovary","volume":"10","author":"Ray","year":"2018","journal-title":"Facts Views Vis. Obgyn"},{"issue":"22","key":"10.1016\/j.semcancer.2020.12.024_bib0565","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1038\/s41388-019-0728-3","article-title":"Regulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC","volume":"38","author":"John","year":"2019","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0570","doi-asserted-by":"crossref","first-page":"13316","DOI":"10.1038\/s41598-019-49649-1","article-title":"Adipocytes promote ovarian cancer chemoresistance","volume":"9","author":"Yang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2020.12.024_bib0575","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s42003-019-0508-1","article-title":"Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells","volume":"2","author":"Chen","year":"2019","journal-title":"Commun Biol"},{"issue":"7","key":"10.1016\/j.semcancer.2020.12.024_bib0580","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/onc.2016.256","article-title":"Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4","volume":"36","author":"Harjes","year":"2017","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.semcancer.2020.12.024_bib0585","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1158\/1078-0432.CCR-14-0445","article-title":"Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancer","volume":"20","author":"Tucker","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2020.12.024_bib0590","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ebiom.2019.04.041","article-title":"NKX2-8 deletion-induced reprogramming of fatty acid metabolism confers chemoresistance in epithelial ovarian cancer","volume":"43","author":"Zhu","year":"2019","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.semcancer.2020.12.024_bib0595","doi-asserted-by":"crossref","first-page":"9587","DOI":"10.3892\/mmr.2017.7783","article-title":"Adiposederived mesenchymal stem cells attenuate cisplatininduced apoptosis in epithelial ovarian cancer cells","volume":"16","author":"Wen","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0600","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s12032-014-0391-z","article-title":"Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer","volume":"32","author":"Cai","year":"2015","journal-title":"Med. Oncol."},{"key":"10.1016\/j.semcancer.2020.12.024_bib0605","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12967-015-0511-3","article-title":"Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer","volume":"13","author":"Bauerschlag","year":"2015","journal-title":"J. Transl. Med."},{"issue":"11","key":"10.1016\/j.semcancer.2020.12.024_bib0610","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/bjc.2017.356","article-title":"TAMeless traitors: macrophages in cancer progression and metastasis","volume":"117","author":"Aras","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2020.12.024_bib0615","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/cancers6031670","article-title":"Tumor-associated macrophages as major players in the tumor microenvironment","volume":"6","author":"Chanmee","year":"2014","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.semcancer.2020.12.024_bib0620","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191869","article-title":"Tissue-resident macrophages in omentum promote metastatic spread of ovarian cancer","volume":"217","author":"Etzerodt","year":"2020","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0625","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ygyno.2018.01.014","article-title":"Tumor associated macrophages in gynecologic cancers","volume":"149","author":"Krishnan","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0630","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ijc.28335","article-title":"Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse","volume":"134","author":"Reinartz","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2020.12.024_bib0635","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.intimp.2016.08.029","article-title":"Tumor-associated macrophages promote invasion via Toll-like receptors signaling in patients with ovarian cancer","volume":"40","author":"Ke","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.semcancer.2020.12.024_bib0640","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1172\/JCI87252","article-title":"Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer","volume":"126","author":"Yin","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0645","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s40425-019-0666-1","article-title":"Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments","volume":"7","author":"Raghavan","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"37","key":"10.1016\/j.semcancer.2020.12.024_bib0650","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1038\/s41388-018-0317-x","article-title":"Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer","volume":"37","author":"Al Habyan","year":"2018","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.semcancer.2020.12.024_bib0655","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10100366","article-title":"Bipolar tumor-associated macrophages in ovarian Cancer as targets for therapy","volume":"10","author":"Gupta","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"46","key":"10.1016\/j.semcancer.2020.12.024_bib0660","doi-asserted-by":"crossref","first-page":"75339","DOI":"10.18632\/oncotarget.12180","article-title":"The transcriptional signature of human ovarian carcinoma macrophages is associated with extracellular matrix reorganization","volume":"7","author":"Finkernagel","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.semcancer.2020.12.024_bib0665","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1172\/JCI84427","article-title":"The impact of hypoxia on tumor-associated macrophages","volume":"126","author":"Henze","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.semcancer.2020.12.024_bib0670","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.3892\/or.2014.3448","article-title":"Reactive oxygen species promote ovarian cancer progression via the HIF-1alpha\/LOX\/E-cadherin pathway","volume":"32","author":"Wang","year":"2014","journal-title":"Oncol. Rep."},{"issue":"12","key":"10.1016\/j.semcancer.2020.12.024_bib0675","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1158\/0008-5472.CAN-06-4375","article-title":"Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice","volume":"67","author":"Robinson-Smith","year":"2007","journal-title":"Cancer Res."},{"issue":"52","key":"10.1016\/j.semcancer.2020.12.024_bib0680","doi-asserted-by":"crossref","first-page":"86608","DOI":"10.18632\/oncotarget.13474","article-title":"M2 macrophages induce ovarian cancer cell proliferation via a heparin binding epidermal growth factor\/matrix metalloproteinase 9 intercellular feedback loop","volume":"7","author":"Carroll","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.semcancer.2020.12.024_bib0685","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/micc.12259","article-title":"Macrophages: an inflammatory link between angiogenesis and lymphangiogenesis","volume":"23","author":"Corliss","year":"2016","journal-title":"Microcirculation"},{"key":"10.1016\/j.semcancer.2020.12.024_bib0690","doi-asserted-by":"crossref","first-page":"8687","DOI":"10.2147\/OTT.S216355","article-title":"Tumor-associated macrophages (TAMs): a critical activator in ovarian Cancer metastasis","volume":"12","author":"Yin","year":"2019","journal-title":"Onco. Ther."},{"issue":"10","key":"10.1016\/j.semcancer.2020.12.024_bib0695","first-page":"1699","article-title":"Regulation of epithelial-mesenchymal transition by tumor-associated macrophages in cancer","volume":"7","author":"Zhang","year":"2015","journal-title":"Am. J. Transl. Res."},{"issue":"8","key":"10.1016\/j.semcancer.2020.12.024_bib0700","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.cellsig.2016.03.016","article-title":"Notch and TGFbeta form a positive regulatory loop and regulate EMT in epithelial ovarian cancer cells","volume":"28","author":"Zhou","year":"2016","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/j.semcancer.2020.12.024_bib0705","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41556-019-0298-1","article-title":"Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response","volume":"21","author":"Salvagno","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.semcancer.2020.12.024_bib0710","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","article-title":"Macrophages and therapeutic resistance in cancer","volume":"27","author":"Ruffell","year":"2015","journal-title":"Cancer Cell"},{"issue":"30","key":"10.1016\/j.semcancer.2020.12.024_bib0715","doi-asserted-by":"crossref","first-page":"12425","DOI":"10.1073\/pnas.1106645108","article-title":"Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem\/initiating cells","volume":"108","author":"Jinushi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.semcancer.2020.12.024_bib0720","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1158\/0008-5472.CAN-12-3542","article-title":"Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment","volume":"73","author":"Dijkgraaf","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2020.12.024_bib0725","doi-asserted-by":"crossref","first-page":"109539","DOI":"10.1016\/j.cellsig.2020.109539","article-title":"GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma","volume":"68","author":"El-Arabey","year":"2020","journal-title":"Cell. Signal."},{"key":"10.1016\/j.semcancer.2020.12.024_bib0730","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2019.12.024","article-title":"Cisplatin-stimulated macrophages promote ovarian cancer migration via the CCL20-CCR6 axis","volume":"472","author":"Liu","year":"2020","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.semcancer.2020.12.024_bib0735","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \"N1\" versus \"N2\" TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2020.12.024_bib0740","doi-asserted-by":"crossref","first-page":"701067","DOI":"10.1155\/2015\/701067","article-title":"Distinct functions of neutrophil in Cancer and its regulation","volume":"2015","author":"Granot","year":"2015","journal-title":"Mediators Inflamm."},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0745","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1210\/er.2011-0014","article-title":"Molecular pathogenesis of granulosa cell tumors of the ovary","volume":"33","author":"Jamieson","year":"2012","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0750","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/imr.12459","article-title":"Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal","volume":"273","author":"Singel","year":"2016","journal-title":"Immunol. Rev."},{"issue":"11","key":"10.1016\/j.semcancer.2020.12.024_bib0755","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00262-013-1476-9","article-title":"Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression","volume":"62","author":"Mishalian","year":"2013","journal-title":"Cancer Immunol. Immunother."},{"issue":"11","key":"10.1016\/j.semcancer.2020.12.024_bib0760","doi-asserted-by":"crossref","first-page":"e1232221","DOI":"10.1080\/2162402X.2016.1232221","article-title":"Tumor-associated neutrophils display a distinct N1 profile following TGFbeta modulation: a transcriptomics analysis of pro- vs. Antitumor TANs","volume":"5","author":"Shaul","year":"2016","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.semcancer.2020.12.024_bib0765","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ccr.2011.08.012","article-title":"Tumor entrained neutrophils inhibit seeding in the premetastatic lung","volume":"20","author":"Granot","year":"2011","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.semcancer.2020.12.024_bib0770","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10090302","article-title":"Regulation of ovarian Cancer prognosis by immune cells in the tumor microenvironment","volume":"10","author":"Drakes","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"16","key":"10.1016\/j.semcancer.2020.12.024_bib0775","doi-asserted-by":"crossref","first-page":"7968","DOI":"10.1158\/0008-5472.CAN-05-4279","article-title":"Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancer","volume":"66","author":"Acuff","year":"2006","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.semcancer.2020.12.024_bib0780","doi-asserted-by":"crossref","first-page":"546","DOI":"10.7150\/jca.14169","article-title":"Neutrophil granulocytes in ovarian Cancer - induction of epithelial-to-Mesenchymal-Transition and tumor cell migration","volume":"7","author":"Mayer","year":"2016","journal-title":"J. Cancer"},{"key":"10.1016\/j.semcancer.2020.12.024_bib0785","first-page":"7943467","article-title":"Neutrophil-to-Lymphocyte ratio is a potential prognostic biomarker in patients with ovarian Cancer: a meta-analysis","volume":"2017","author":"Chen","year":"2017","journal-title":"Biomed Res. Int."},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0790","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3233\/CBM-160614","article-title":"Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy","volume":"17","author":"Miao","year":"2016","journal-title":"Cancer Biomark."},{"issue":"8","key":"10.1016\/j.semcancer.2020.12.024_bib0795","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00262-012-1294-5","article-title":"Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology","volume":"61","author":"Dumitru","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"issue":"2","key":"10.1016\/j.semcancer.2020.12.024_bib0800","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.18632\/oncotarget.12278","article-title":"On the origin of myeloid-derived suppressor cells","volume":"8","author":"Millrud","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0805","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ijc.23083","article-title":"Involvement of SDF-1alpha\/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma","volume":"122","author":"Kajiyama","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2020.12.024_bib0810","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/modpathol.2008.187","article-title":"Classification using hierarchical clustering of tumor-infiltrating immune cells identifies poor prognostic ovarian cancers with high levels of COX expression","volume":"22","author":"Liu","year":"2009","journal-title":"Mod. Pathol."},{"issue":"16","key":"10.1016\/j.semcancer.2020.12.024_bib0815","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1158\/0008-5472.CAN-10-3143","article-title":"CXCL12\/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer","volume":"71","author":"Righi","year":"2011","journal-title":"Cancer Res."},{"issue":"15","key":"10.1016\/j.semcancer.2020.12.024_bib0820","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.7150\/jca.20314","article-title":"Immune cell population in ovarian tumor microenvironment","volume":"8","author":"Cai","year":"2017","journal-title":"J. Cancer"},{"issue":"4","key":"10.1016\/j.semcancer.2020.12.024_bib0825","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1172\/JCI60083","article-title":"STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients","volume":"123","author":"Vasquez-Dunddel","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcancer.2020.12.024_bib0830","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3389\/fimmu.2019.01273","article-title":"Myeloid derived suppressor cells: key drivers of immunosuppression in ovarian Cancer","volume":"10","author":"Baert","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2020.12.024_bib0835","doi-asserted-by":"crossref","first-page":"18217","DOI":"10.1038\/srep18217","article-title":"The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer","volume":"5","author":"Kawano","year":"2015","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.semcancer.2020.12.024_bib0840","doi-asserted-by":"crossref","first-page":"e27690","DOI":"10.1371\/journal.pone.0027690","article-title":"Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism","volume":"6","author":"Waight","year":"2011","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.semcancer.2020.12.024_bib0845","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1182\/blood-2012-04-425397","article-title":"NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)","volume":"121","author":"Romee","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.semcancer.2020.12.024_bib0850","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/IGC.0000000000000672","article-title":"Combined immunoscore of CD103 and CD3 identifies long-term survivors in high-grade serous ovarian Cancer","volume":"26","author":"Bosmuller","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2020.12.024_bib0855","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1158\/1078-0432.CCR-13-1877","article-title":"Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer","volume":"20","author":"Webb","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.semcancer.2020.12.024_bib0860","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nm.4278","article-title":"A distinct innate lymphoid cell population regulates tumor-associated T cells","volume":"23","author":"Crome","year":"2017","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.semcancer.2020.12.024_bib0865","first-page":"9428","article-title":"B7-H6 expression correlates with cancer progression and patient\u2019s survival in human ovarian cancer","volume":"8","author":"Zhou","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.semcancer.2020.12.024_bib0870","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.3389\/fimmu.2019.01782","article-title":"Naturally killing the silent killer: NK cell-based immunotherapy for ovarian Cancer","volume":"10","author":"Nersesian","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.semcancer.2020.12.024_bib0875","doi-asserted-by":"crossref","first-page":"e1001224","DOI":"10.1080\/2162402X.2014.1001224","article-title":"B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape","volume":"4","author":"Pesce","year":"2015","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.semcancer.2020.12.024_bib0880","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ygyno.2005.07.030","article-title":"Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125","volume":"99","author":"Patankar","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.semcancer.2020.12.024_bib0885","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11040461","article-title":"Natural killer cells as key players of tumor progression and angiogenesis: old and novel tools to divert their pro-tumor activities into potent anti-tumor effects","volume":"11","author":"Bassani","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.semcancer.2020.12.024_bib0890","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3389\/fimmu.2018.00527","article-title":"Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment: implications for immunotherapy","volume":"9","author":"Albini","year":"2018","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.semcancer.2020.12.024_bib0895","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093125","article-title":"The ovarian Cancer tumor immune microenvironment (TIME) as target for therapy: a focus on innate immunity cells as therapeutic effectors","volume":"21","author":"Baci","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.semcancer.2020.12.024_bib0900","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1096\/fj.201701103R","article-title":"Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer","volume":"32","author":"Bruno","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.semcancer.2020.12.024_bib0905","doi-asserted-by":"crossref","first-page":"2438598","DOI":"10.1155\/2018\/2438598","article-title":"Natural killer cells from malignant pleural effusion are endowed with a decidual-like proangiogenic polarization","volume":"2018","author":"Bosi","year":"2018","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0910","doi-asserted-by":"crossref","first-page":"7958","DOI":"10.1038\/s41598-017-08483-z","article-title":"Enhancing NK cell-mediated cytotoxicity to cisplatin-resistant lung cancer cells via MEK\/Erk signaling inhibition","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.semcancer.2020.12.024_bib0915","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.3892\/ijo.2013.1846","article-title":"Immune escape of AKT overexpressing ovarian cancer cells","volume":"42","author":"Hahne","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.semcancer.2020.12.024_bib0920","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.coi.2014.01.004","article-title":"New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape","volume":"27","author":"Mittal","year":"2014","journal-title":"Curr. Opin. Immunol."},{"issue":"10","key":"10.1016\/j.semcancer.2020.12.024_bib0925","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1002\/cam4.1741","article-title":"Role of tumor microenvironment in the pathobiology of ovarian cancer: insights and therapeutic opportunities","volume":"7","author":"Ghoneum","year":"2018","journal-title":"Cancer Med."},{"issue":"3","key":"10.1016\/j.semcancer.2020.12.024_bib0930","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/diagnostics10030146","article-title":"Immune checkpoint inhibitors in epithelial ovarian Cancer: an overview on efficacy and future perspectives","volume":"10","author":"Borella","year":"2020","journal-title":"Diagnostics Basel (Basel)"},{"issue":"6","key":"10.1016\/j.semcancer.2020.12.024_bib0935","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/15384047.2015.1040960","article-title":"Tumor infiltrating lymphocytes in ovarian cancer","volume":"16","author":"Santoiemma","year":"2015","journal-title":"Cancer Biol. Ther."},{"issue":"2","key":"10.1016\/j.semcancer.2020.12.024_bib0940","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ygyno.2011.09.039","article-title":"Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis","volume":"124","author":"Hwang","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.semcancer.2020.12.024_bib0945","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1158\/0008-5472.CAN-12-4100","article-title":"Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors","volume":"73","author":"Duraiswamy","year":"2013","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.semcancer.2020.12.024_bib0950","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41416-019-0384-y","article-title":"Tumour-reactive T cell subsets in the microenvironment of ovarian cancer","volume":"120","author":"Westergaard","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"5594","key":"10.1016\/j.semcancer.2020.12.024_bib0955","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1076514","article-title":"Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes","volume":"298","author":"Dudley","year":"2002","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.semcancer.2020.12.024_bib0960","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.cell.2016.04.009","article-title":"Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer","volume":"165","author":"Wang","year":"2016","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.semcancer.2020.12.024_bib0965","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1158\/0008-5472.CAN-16-0881","article-title":"Tumor eradication by cisplatin is sustained by CD80\/86-Mediated costimulation of CD8+ t cells","volume":"76","author":"Beyranvand Nejad","year":"2016","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.semcancer.2020.12.024_bib0970","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00262-009-0749-9","article-title":"The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy","volume":"59","author":"Wu","year":"2010","journal-title":"Cancer Immunol. Immunother."},{"issue":"4","key":"10.1016\/j.semcancer.2020.12.024_bib0975","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2217\/imt.11.20","article-title":"Immunity and immune suppression in human ovarian cancer","volume":"3","author":"Preston","year":"2011","journal-title":"Immunotherapy"},{"issue":"4","key":"10.1016\/j.semcancer.2020.12.024_bib0980","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/cdd.2015.3","article-title":"The role of CD95 and CD95 ligand in cancer","volume":"22","author":"Peter","year":"2015","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib0985","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.semcancer.2020.12.024_bib0990","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/cas.12445","article-title":"Indoleamine 2,3-dioxygenase promotes peritoneal metastasis of ovarian cancer by inducing an immunosuppressive environment","volume":"105","author":"Tanizaki","year":"2014","journal-title":"Cancer Sci."},{"issue":"11","key":"10.1016\/j.semcancer.2020.12.024_bib0995","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1158\/2326-6066.CIR-15-0044","article-title":"CTLA-4 blockade synergizes therapeutically with PARP inhibition in BRCA1-Deficient ovarian Cancer","volume":"3","author":"Higuchi","year":"2015","journal-title":"Cancer Immunol. Res."},{"issue":"9","key":"10.1016\/j.semcancer.2020.12.024_bib1000","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1073\/pnas.0611533104","article-title":"Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer","volume":"104","author":"Hamanishi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.semcancer.2020.12.024_bib1005","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/2326-6066.CIR-15-0073","article-title":"Decitabine enhances lymphocyte migration and function and synergizes with CTLA-4 blockade in a murine ovarian Cancer model","volume":"3","author":"Wang","year":"2015","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib1010","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygyno.2017.07.007","article-title":"Prognostic significance of tumor-associated macrophages in ovarian cancer: a meta-analysis","volume":"147","author":"Yuan","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.semcancer.2020.12.024_bib1015","doi-asserted-by":"crossref","DOI":"10.1177\/1533033818791500","article-title":"Prognostic role of neutrophil to lymphocyte ratio in ovarian Cancer: a meta-analysis","volume":"17","author":"Chen","year":"2018","journal-title":"Technol. Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.semcancer.2020.12.024_bib1020","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ygyno.2011.09.039","article-title":"Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis","volume":"124","author":"Hwang","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib1025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jcb.24317","article-title":"Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance","volume":"114","author":"Ahmed","year":"2013","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib1030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0046-8177(95)90119-1","article-title":"Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer","volume":"26","author":"Brown","year":"1995","journal-title":"Hum. Pathol."},{"issue":"5","key":"10.1016\/j.semcancer.2020.12.024_bib1035","first-page":"1029","article-title":"Vascular permeability factor\/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis","volume":"146","author":"Dvorak","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.semcancer.2020.12.024_bib1040","first-page":"129","article-title":"Angiogenesis and the tumor vasculature as antitumor immune modulators: the role of vascular endothelial growth factor and endothelin","volume":"344","author":"Kandalaft","year":"2011","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"4","key":"10.1016\/j.semcancer.2020.12.024_bib1045","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1006\/bbrc.2002.6710","article-title":"Different effects of glucose starvation on expression and stability of VEGF mRNA isoforms in murine ovarian cancer cells","volume":"292","author":"Zhang","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.semcancer.2020.12.024_bib1050","first-page":"3403","article-title":"Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer","volume":"63","author":"Zhang","year":"2003","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.semcancer.2020.12.024_bib1055","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1158\/1535-7163.MCT-06-0447","article-title":"Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells","volume":"5","author":"Lorenzi","year":"2006","journal-title":"Mol. Cancer Ther."},{"issue":"50","key":"10.1016\/j.semcancer.2020.12.024_bib1060","doi-asserted-by":"crossref","first-page":"83148","DOI":"10.18632\/oncotarget.13074","article-title":"Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro","volume":"7","author":"Kim","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.semcancer.2020.12.024_bib1065","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrc3432","article-title":"Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research","volume":"13","author":"Kipps","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.semcancer.2020.12.024_bib1070","first-page":"1108","article-title":"Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites","volume":"8","author":"Milliken","year":"2002","journal-title":"Clin. Cancer Res."},{"issue":"44","key":"10.1016\/j.semcancer.2020.12.024_bib1075","doi-asserted-by":"crossref","first-page":"76843","DOI":"10.18632\/oncotarget.20164","article-title":"Ascites-derived IL-6 and IL-10 synergistically expand CD14(+)HLA-DR(-\/low) myeloid-derived suppressor cells in ovarian cancer patients","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib1080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13048-018-0391-2","article-title":"Comparison of benign peritoneal fluid- and ovarian cancer ascites-derived extracellular vesicle RNA biomarkers","volume":"11","author":"Yamamoto","year":"2018","journal-title":"J. Ovarian Res."},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib1085","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ygyno.2003.12.034","article-title":"Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers","volume":"93","author":"Burleson","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"16","key":"10.1016\/j.semcancer.2020.12.024_bib1090","first-page":"3830","article-title":"Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H","volume":"53","author":"Cannistra","year":"1993","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.semcancer.2020.12.024_bib1095","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0304-3835(95)03743-G","article-title":"Expression of cell adhesion molecules on ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasis","volume":"91","author":"Gardner","year":"1995","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.semcancer.2020.12.024_bib1100","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1002\/ijc.24627","article-title":"Restriction of cisplatin induction of acute apoptosis to a subpopulation of cells in a three-dimensional carcinoma culture model","volume":"125","author":"Fayad","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2020.12.024_bib1105","first-page":"878","article-title":"Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy","volume":"8","author":"Tannock","year":"2002","journal-title":"Clin. Cancer Res."},{"issue":"22","key":"10.1016\/j.semcancer.2020.12.024_bib1110","doi-asserted-by":"crossref","first-page":"E1974","DOI":"10.1073\/pnas.1216989110","article-title":"Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules","volume":"110","author":"Rizvi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.semcancer.2020.12.024_bib1115","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ygyno.2007.10.018","article-title":"Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy","volume":"108","author":"Bamias","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib1120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ygyno.2007.02.029","article-title":"Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance","volume":"106","author":"Bamias","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.semcancer.2020.12.024_bib1125","first-page":"2875","article-title":"Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity","volume":"29","author":"Giuntoli","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.semcancer.2020.12.024_bib1130","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.32990","article-title":"Metabolic factors contribute to T-cell inhibition in the ovarian cancer ascites","author":"Gong","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2020.12.024_bib1135","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.bbrc.2020.03.136","article-title":"Suppression of ovarian cancer by low-intensity ultrasound through depletion of IL-6\/STAT3 inflammatory pathway-maintained cancer stemness","volume":"526","author":"Gong","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib1140","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1757-2215-5-34","article-title":"Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis","volume":"5","author":"Lane","year":"2012","journal-title":"J. Ovarian Res."},{"issue":"5","key":"10.1016\/j.semcancer.2020.12.024_bib1145","first-page":"566","article-title":"Profiling of cytokines in human epithelial ovarian cancer ascites","volume":"2","author":"Matte","year":"2012","journal-title":"Am. J. Cancer Res."},{"issue":"13","key":"10.1016\/j.semcancer.2020.12.024_bib1150","doi-asserted-by":"crossref","first-page":"11310","DOI":"10.18632\/oncotarget.3597","article-title":"Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer","volume":"6","author":"Khan","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib1155","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/IGC.0000000000000307","article-title":"Oxaliplatin is a safe alternative option for patients with recurrent gynecologic cancers after hypersensitivity reaction to Carboplatin","volume":"25","author":"Kolomeyevskaya","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2020.12.024_bib1160","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00109-012-0946-4","article-title":"Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2","volume":"91","author":"Cohen","year":"2013","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.semcancer.2020.12.024_bib1165","doi-asserted-by":"crossref","first-page":"2873030","DOI":"10.1155\/2017\/2873030","article-title":"Markers of oxidative stress and inflammation in ascites and plasma in patients with platinum-sensitive, Platinum-Resistant, and platinum-refractory epithelial ovarian Cancer","volume":"2017","author":"Canton-Romero","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.semcancer.2020.12.024_bib1170","article-title":"Challenges for immunotherapy for the treatment of platinum resistant ovarian cancer","author":"Le Saux","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"4","key":"10.1016\/j.semcancer.2020.12.024_bib1175","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrc2355","article-title":"Adoptive cell transfer: a clinical path to effective cancer immunotherapy","volume":"8","author":"Rosenberg","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2020.12.024_bib1180","doi-asserted-by":"crossref","first-page":"8015","DOI":"10.2147\/OTT.S203550","article-title":"Advances of chimeric antigen receptor t cell therapy in ovarian Cancer","volume":"12","author":"Yan","year":"2019","journal-title":"Onco. Ther."},{"issue":"38","key":"10.1016\/j.semcancer.2020.12.024_bib1185","doi-asserted-by":"crossref","first-page":"64607","DOI":"10.18632\/oncotarget.19929","article-title":"CAR-T cell therapy in ovarian cancer: from the bench to the bedside","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.semcancer.2020.12.024_bib1190","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1089\/hum.2017.168","article-title":"Improved killing of ovarian Cancer stem cells by combining a novel chimeric antigen receptor-based immunotherapy and chemotherapy","volume":"28","author":"Klapdor","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.semcancer.2020.12.024_bib1195","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.gore.2019.06.003","article-title":"Checkpoint inhibitors in ovarian cancer: a review of preclinical data","volume":"29","author":"Doo","year":"2019","journal-title":"Gynecol. Oncol. Rep."},{"issue":"5","key":"10.1016\/j.semcancer.2020.12.024_bib1200","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.3802\/jgo.2019.30.e105","article-title":"How to use immune checkpoint inhibitor in ovarian cancer?","volume":"30","author":"Park","year":"2019","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.semcancer.2020.12.024_bib1205","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3389\/fimmu.2019.00867","article-title":"Atezolizumab and Bevacizumab attenuate cisplatin resistant ovarian Cancer cells progression synergistically via suppressing epithelial-mesenchymal transition","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib1210","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2016.04.025","article-title":"Identification of a subset of human natural killer cells expressing high levels of programmed death 1: a phenotypic and functional characterization","volume":"139","author":"Pesce","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.semcancer.2020.12.024_bib1215","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3390\/cancers11050668","article-title":"Review: targeting the transforming growth factor-beta pathway in ovarian Cancer","volume":"11","author":"Roane","year":"2019","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.semcancer.2020.12.024_bib1220","doi-asserted-by":"crossref","first-page":"9227","DOI":"10.1038\/s41598-018-27521-y","article-title":"Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets","volume":"8","author":"Nagy","year":"2018","journal-title":"Sci. Rep."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X21000031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X21000031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:51:21Z","timestamp":1760917881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X21000031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":244,"alternative-id":["S1044579X21000031"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2020.12.024","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the clinical value of tumor microenvironment in platinum-resistant ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2020.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}